|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 2, 2006.
Revised August 14, 2006.
Accepted for publication September 8, 2006.
2,3-butanedione monoxime (BDM) is widely believed to act as a chemical phosphatase. We therefore examined BDM's effects on the cystic fibrosis transmembrane regulator (CFTR) Cl- channel, which is regulated by phosphorylation in a complex manner. In guinea pig ventricular myocytes, forskolin-activated whole-cell CFTR currents responded biphasically to external 20 mM BDM: a rapid ~2-fold current activation was followed by a slower (
~20 s) current inhibition (to ~20 % of control). The inhibitory response was abolished by intracellular dialysis with the phosphatase inhibitor microcystin, suggesting the involvement of endogenous phosphatases. The BDM-induced activation was studied further in Xenopus oocytes expressing human epithelial CFTR. The concentration for half-maximal BDM activation (K0.5) was state-dependent, ~2 mM for highly and ~20 mM for partially phosphorylated channels, suggesting a modulated receptor mechanism. Because BDM modulates many different membrane proteins with similar K0.5s, we tested whether BDM could alter protein function by altering lipid bilayer properties rather than by direct BDM-protein interaction. Using gramicidin channels of different lengths (different channel-bilayer hydrophobic mismatch) as reporters of bilayer properties, we found that BDM increases channel appearance rates and lifetimes (reduces bilayer stiffness). At 20 mM BDM, the appearance rates increase ~4 fold (for the longer, 15 residues/monomer, channels) to ~10 fold (for the shorter, 13 residues/monomer, channels); the lifetimes increase ~50% independent of channel length. BDM thus reduces the energetic cost of bilayer deformation, an effect that may underlie BDM's effects on CFTR and other membrane proteins; the state-dependent changes in K0.5 are consistent with such a bilayer-mediated mechanism.
Key words:
Ion channel regulation, Ion transporters (SERCA, Na/K ATPase, CFTR)